Skip to Main Content

COVID-19: Impact on Hospitals of the Temporary Elimination of the 2% Medicare Sequestration Cuts

Date: 16 April 2020
U.S. Health Care Alert

Certain provisions of the recent CARES Act1  impact how hospitals are reimbursed under original Fee-For-Service Medicare (i.e., Part A and Part B) and existing Medicare Advantage contracts. Specifically, the CARES Act temporarily suspends the 2% Medicare sequestration cuts between May 1, 2020 through December 31, 2020.2 However, the CARES Act also extends mandatory sequestration for an additional year, through fiscal year 2030. This Alert:

  1. outlines the contexts in which this temporary “Sequestration Cut Abeyance Period” may impact hospitals’ Medicare and Medicare Advantage reimbursement; and
  2. warns of issues for hospitals to monitor.

Original Medicare and OON Medicare Advantage

The impact of the Sequestration Cut Abeyance Period on original Medicare is easy to discern. For original Medicare, payments to hospitals will not be reduced by the historical 2% sequestration cuts during this Sequestration Cut Abeyance Period. Effectively, this should result in a 2% increase in Fee-For-Service Medicare payments. The impact is equally clear for hospitals that are out-of-network (“OON”) with a Medicare Advantage Organization (“MAO”) payor. Hospitals with any OON MAOs should see the same result as with original Medicare. The sequestration cuts that OON MAOs are historically allowed to pass along, should not be imposed during the Sequestration Cut Abeyance Period because there are no such cuts to pass along.

In-Network Medicare Advantage Contracts

For hospitals that are in-network with an MAO, the Sequestration Cut Abeyance Period’s impact will depend on the terms of the parties’ Medicare Advantage Agreement (the “Agreement”) and whether the MAO has been passing along the 2% cuts prior to the Sequestration Cut Abeyance Period. For an in-network hospital, where the MAO has not historically passed along the 2% cuts per the Agreement, there should be no impact. In other words, if the 2% cut was not passed along prior to the Sequestration Cut Abeyance Period, such cuts would obviously be inappropriate for an MAO to impose on an in-network hospital when there are no cuts to pass along during the Sequestration Cut Abeyance Period.

For any in-network hospitals where the MAO has historically passed along the 2% cuts per the Agreement, such hospitals should examine their Agreement language to make sure the MAO is complying with the Agreement’s reimbursement terms during the Sequestration Cut Abeyance Period. Although the outcome will depend on each Agreement’s language, it should be rare language that would permit an MAO to continue “passing along” the 2% cut during this Sequestration Cut Abeyance Period when there is no cut to pass along. Thus, in-network hospitals should verify that any sequestration cuts historically imposed by their MAO do not simply continue on auto-pilot during this Sequestration Cut Abeyance Period.

If hospitals want help interpreting their Medicare Advantage Agreements regarding this Sequestration Cut Abeyance Period, we have experience interpreting, negotiating, and litigating in this area, and would be happy to assist.

1 Section 3709 of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) imposes what we are calling the “Sequestration Cut Abeyance Period.”

2 Id.

Gary S. Qualls
Gary S. Qualls
Research Triangle Park
View
Steven G. Pine
Steven G. Pine
Research Triangle Park
View

This publication/newsletter is for informational purposes and does not contain or convey legal advice. The information herein should not be used or relied upon in regard to any particular facts or circumstances without first consulting a lawyer. Any views expressed herein are those of the author(s) and not necessarily those of the law firm's clients.

Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel